For a vaccine to work, people need to take it. But some are hesitant. On this week's How to Vaccinate the World, Tim Harford looks at why some people have concerns about taking a new coronavirus vaccine - and discussing how health providers, governments and the media should be responding. Tim is joined this week by GP Margaret McCartney, Marianna Spring, BBC Disinformation and Social Media Correspondent, and Professor Heidi Larson, Director of The Vaccine Confidence Project at London School of Hygiene and Tropical Medicine and author of Stuck: How Vaccine Rumours Start.
Wissenschaft & TechnikGesundheit, Wellness & Beauty
How to Vaccinate the World Folgen
Scientists are racing to create a vaccine to end the Covid-19 pandemic.But creating a workable vaccine is just the start. Tim Harford is your guide to this epic global undertaking.
Folgen von How to Vaccinate the World
22 Folgen
-
Folge vom 14.12.2020Vaccine Hesitancy
-
Folge vom 07.12.2020The First ShotsSo, after much waiting and hoping, a Covid 19 vaccine has been approved for use in the UK. Now the roll out begins. But, it’s not easy moving around a vaccine that has to be stored at temperatures of an Antarctic winter, or organising two doses of the jab for the most vulnerable people around the country. On this week’s How To Vaccinate The World, Tim Harford talks with a group of experts about the complicated logistics of a vaccination programme being worked out in real time. Programme producers: Sandra Kanthal and Josephine Casserly
-
Folge vom 30.11.2020The Oxford/AstraZeneca VaccineTim Harford reports on what we know and don't know about the Oxford/Astra Zeneca Covid 19 vaccine, as well as answering questions from both the audience and our editor. On this week's panel of experts is Danny Altman, Professor of Immunology at Imperial College London, Jennifer Rogers, Head of Statistical Research and Consultancy at Phastar and Natasha Loder, Health and Policy Editor at the Economist.
-
Folge vom 23.11.2020Who gets it?It looks like we may finally be getting a coronavirus vaccine. But who’s “we”? Who is at the front of the queue, and who should be at the front of the queue? Should it be those with the greatest need or the highest bidder?In the second of the series, Tim Harford talks to GP Margaret McCartney, health economist Professor Philip Clarke and biological engineer Dr Anna Blakney.Contact us: vaccine@bbc.co.uk